Nancy Briggs

Nancy Briggs

Auto-generated profile, based on publicly available information

Nancy Briggs

University of New South Wales Sydney New South Wales Australia

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008
Verified
Book
Closed access
KPKristopher Preacher
Kristopher Preacher
AWAaron Wichman
Aaron Wichman
RMRobert MacCallum
Robert MacCallum
NBNancy Briggs
Nancy Briggs
Latent growth curve modeling (LGM) is an indispensable and increasingly ubiquitous approach for modeling longitudinal data. This book introduces LGMtechnique

1 January 2003 in Multivariate Behavioral Research
Verified
Journal Article
Closed access
NBNancy E. Briggs
Nancy E. Briggs
RMRobert C. MacCallum
Robert C. MacCallum
This article examines the relative performance of two commonly used methods of parameter estimation in factor analysis, maximum likelihood (ML) and ordinary least squares (OLS). It is shown that ML will sometimes fail to recover a known population factor structure when OLS succeeds. A simulation study was conducted in which two types of error (model and sampling error) were introduced separately and in combination into correlation matrices generated from known population structures with at least one relatively weak major domain factor. Simulated correlation matrices were factor analyzed using both ML and OLS, and recovery of the relatively weak factor(s) was assessed. In situations with a moderate amount of error, ML often failed to recover the weak factor while OLS succeeded. It is suggested that the correspondence between the assumptions inherent in each method regarding error and the actual nature of error in the data may affect the success of recovery of weak common factors. An example using empirical...

9 May 2013 in Blood
Verified
Journal Article
Closed access
PDF file
SBSusan Branford
Susan Branford
DYDavid T. Yeung
David T. Yeung
DRDavid Morrall Ross
David Morrall Ross
JPJodi A. Prime
Jodi A. Prime
CFChani R. Field
Chani R. Field
THTimothy Peter Hughes
Timothy Peter Hughes
Recent studies have demonstrated that some patients with chronic myeloid leukemia (CML) can maintain remission after discontinuation of imatinib. A prerequisite is stable, undetectable BCR-ABL1. It is not known how many patients achieve this response or the factors associated with its achievement. We examined 423 de novo imatinib-treated patients to determine the cumulative incidence of achieving the discontinuation criteria as defined in the CML8 study (≥2 years of undetectable BCR-ABL1 [Stable MR4.5]), and predictive factors. After 8 years of imatinib, the cumulative incidence of Stable MR4.5 was 36.5%. Therefore, 9% to 15% of first-line imatinib-treated patients would maintain remission after discontinuation. The BCR-ABL1 level at 3 months and factors at diagnosis were examined for association with Stable MR4.5: Sokal risk, age, sex, and assigned imatinib dose. The only independent predictors were female sex (54.4% vs 27.2%; P = .018) and the 3-month BCR-ABL1 (P < .001). The highest cumulative incidence of Stable MR4.5 after 8 years was 78.2% for patients with BCR-ABL1 ≤ 0.10%IS at 3 months (n = 38). Time to major molecular response (MMR) influenced the time to reach Stable MR4.5 (P < .001), suggesting slower dynamics of response with a delayed MMR. The findings justify the focus on rapid reduction of BCR-ABL1 as a strategy to maximize potential suitability for imatinib discontinuation studies. The Iris trial was registered at http://www.clinicaltrials.gov as NCT00006343. The Tops trial was registered at http://www.clinicaltrials.gov as NCT00124748. The TIDEL I trial was registered at www.ANZCTR.org.au as ACTRN12607000614493. The TIDEL II trial was registered at www.ANZCTR.org.au as ACTRN12607000325404.

10 November 2016 in Journal of Clinical Child & Adolescent Psychology
Verified
Journal Article
Closed access
EKEva R. Kimonis
Eva R. Kimonis
GFGeorgette Fleming
Georgette Fleming
NBNancy Briggs
Nancy Briggs
LBLauren Brouwer-French
Lauren Brouwer-French
PFPaul J. Frick
Paul J. Frick
MDMark Dadds
Mark Dadds
Children with co-occurring conduct problems and callous-unemotional (CU) traits show a distinct pattern of early starting, chronic, and aggressive antisocial behaviors that are resistant to traditional parent-training interventions. The aim of this study was to examine in an open trial the acceptability and initial outcomes of a novel adaptation of Parent–Child Interaction Therapy, called PCIT-CU, designed to target 3 distinct deficits of children with CU traits. Twenty-three Australian families with a 3- to 6-year-old (M age = 4.5 years, SD = .92) child with clinically significant conduct problems and CU traits participated in the 21-week intervention and 5 assessments measuring child conduct problems, CU traits, and empathy at a university-based research clinic. Treatment retention was high (74%), and parents reported a high level of satisfaction with the program. Results of linear mixed models indicated that the intervention produced decreases in child conduct problems and CU traits, and increases in empathy, with “medium” to “huge” effect sizes (ds = 0.7–2.0) that maintained at a 3-month follow-up. By 3 months posttreatment, 75% of treatment completers no longer showed clinically significant conduct problems relative to 25% of dropouts. Findings provide preliminary support for using the targeted PCIT-CU adaptation to treat young children with conduct problems and co-occurring CU traits.

6 April 2021 in BMJ
Verified
Journal Article
Open access
PDF file
KDKim Delbaere
Kim Delbaere
TVTrinidad Valenzuela
Trinidad Valenzuela
SLStephen Lord
Stephen Lord
LCLindy Clemson
Lindy Clemson
GZG A Rixt Zijlstra
G A Rixt Zijlstra
Kim Van SchootenKim Van Schooten
Kim Van Schooten
Objective To test whether StandingTall, a home based, e-health balance exercise programme delivered through an app, could provide an effective, self-managed fall prevention programme for community dwelling older people. Design Assessor blinded, randomised controlled trial. Setting Older people living independently in the community in Sydney, Australia. Participants 503 people aged 70 years and older who were independent in activities of daily living, without cognitive impairment, progressive neurological disease, or any other unstable or acute medical condition precluding exercise. Interventions Participants were block randomised to an intervention group (two hours of StandingTall per week and health education; n=254) or a control group (health education; n=249) for two years. Main outcome measures The primary outcomes were the rate of falls (number of falls per person year) and the proportion of people who had a fall over 12 months. Secondary outcomes were the number of people who had a fall and the number who had an injurious fall (resulting in any injury or requiring medical care), adherence, mood, health related quality of life, and activity levels over 24 months; and balance and mobility outcomes over 12 months. Results The fall rates were not statistically different in the two groups after the first 12 months (0.60 falls per year (standard deviation 1.05) in the intervention group; 0.76 (1.25) in the control group; incidence rate ratio 0.84, 95% confidence interval 0.62 to 1.13, P=0.071). Additionally, the proportion of people who fell was not statistically different at 12 months (34.6% in intervention group, 40.2% in control group; relative risk 0.90, 95% confidence interval 0.67 to 1.20, P=0.461). However, the intervention group had a 16% lower rate of falls over 24 months compared with the control group (incidence rate ratio 0.84, 95% confidence interval 0.72 to 0.98, P=0.027). Both groups had a similar proportion of people who fell over 24 months (relative risk 0.87, 95% confidence interval 0.68 to 1.10, P=0.239), but the proportion of people who had an injurious fall over 24 months was 20% lower in the intervention group compared with the control group (relative risk 0.80, 95% confidence interval 0.66 to 0.98, P=0.031). In the intervention group, 68.1% and 52.0% of participants exercised for a median of 114.0 min/week (interquartile range 53.5) after 12 months and 120.4 min/week (38.6) after 24 months, respectively. Groups remained similar in mood and activity levels. The intervention group had a 0.03 (95% confidence interval 0.01 to 0.06) improvement on the EQ-5D-5L (EuroQol five dimension five level) utility score at six months, and an improvement in standing balance of 11 s (95% confidence interval 2 to 19 s) at six months and 10 s (1 to 19 s) at 12 months. No serious training related adverse events occurred. Conclusions The StandingTall balance exercise programme did not significantly affect the primary outcomes of this study. However, the programme significantly reduced the rate of falls and the number of injurious falls over two years, with similar but not statistically significant effects at 12 months. E-health exercise programmes could provide promising scalable fall prevention strategies. Trial registration ACTRN12615000138583

27 March 2013 in Nephrology
Verified
Journal Article
Closed access
PDF file
ASAhmed Kaithal Shahir
Ahmed Kaithal Shahir
NBNancy Briggs
Nancy Briggs
JKJohn Katsoulis
John Katsoulis
VLVicki Levidiotis
Vicki Levidiotis